Exact Mass: 659.2777406

Exact Mass Matches: 659.2777406

Found 55 metabolites which its exact mass value is equals to given mass value 659.2777406, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pyridin-2-ylmethyl N-[(2S)-1-[[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate

Pyridin-2-ylmethyl N-[(2S)-1-[[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamic acid

C35H41N5O6S (659.2777406)


   

Aripiprazole lauroxil

Dodecanoic acid, (7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2-oxo-1(2H)-quinolinyl)methyl ester

C36H51Cl2N3O4 (659.3256426)


   

Beclabuvir

19-cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-{3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl}-12-azapentacyclo[10.7.0.0^{2,7}.0^{8,10}.0^{13,18}]nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide

C36H45N5O5S (659.314124)


   

Carminomycin II

8-acetyl-10-[(4-amino-5-{3-hydroxy-1-[(1-hydroxypropan-2-yl)oxy]butoxy}-6-methyloxan-2-yl)oxy]-1,6,8,11-tetrahydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C33H41NO13 (659.2577776)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors

   
   
   

Carminomycin II

Carminomycin II

C33H41NO13 (659.2577776)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors

   
   

alpha-L-Rha-(1-2)-alpha-L-Rha-(1-3)-alpha-L-Rha-(1-3)-beta-D-GlcNAc|alphaLRha(1-2)alphaLRha(1-3)alphaLRha(1-3)betaDGlcNac

alpha-L-Rha-(1-2)-alpha-L-Rha-(1-3)-alpha-L-Rha-(1-3)-beta-D-GlcNAc|alphaLRha(1-2)alphaLRha(1-3)alphaLRha(1-3)betaDGlcNac

C26H45NO18 (659.263651)


   
   

3,12-diacetyl-7-benzoyl-8-nicotinylingol

3,12-diacetyl-7-benzoyl-8-nicotinylingol

C37H41NO10 (659.2730326000001)


   
   
   

N, N, N-Diferuloyl, caffeoylspermidine

N, N, N-Diferuloyl, caffeoylspermidine

C36H41N3O9 (659.2842656)


   

Glu Trp Tyr Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Glu Tyr Trp Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Glu Tyr Tyr Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Trp Glu Tyr Tyr

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Trp Tyr Glu Tyr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Trp Tyr Tyr Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C34H37N5O9 (659.2591152)


   

Tyr Glu Trp Tyr

(4S)-4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Tyr Glu Tyr Trp

(4S)-4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Tyr Trp Glu Tyr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Tyr Trp Tyr Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C34H37N5O9 (659.2591152)


   

Tyr Tyr Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O9 (659.2591152)


   

Tyr Tyr Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C34H37N5O9 (659.2591152)


   

QQQEQ

Gln Gln Gln Glu Gln

C25H41N9O12 (659.2874546)


   

2,6-Bis(tributylstannyl)pyridine

2,6-Bis(tributylstannyl)pyridine

C29H57NSn2 (659.2534742)


   

Beclabuvir

beclabuvir HCl

C36H45N5O5S (659.314124)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Aripiprazole lauroxil

Aripiprazole lauroxil

C36H51Cl2N3O4 (659.3256426)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Pramiconazole

Pramiconazole

C35H39F2N7O4 (659.3031437999999)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Fiboflapon sodium

Fiboflapon sodium

C38H42N3NaO4S (659.2793572)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

Dobutamine lactobionate

Dobutamine lactobionate

C30H45NO15 (659.278906)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Valemetostat tosylate

Valemetostat tosylate

C33H42ClN3O7S (659.2431852)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor

   

Hydergine

Hydergine

C32H45N5O8S (659.2988690000001)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D002491 - Central Nervous System Agents > D018697 - Nootropic Agents > D004877 - Ergoloid Mesylates D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene

1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene

C27H41N5O14 (659.2649886)


   

2-O-sulfonato-alpha-D-glucopyranosyl 2-O-hexadecanoyl-alpha-D-glucopyranoside

2-O-sulfonato-alpha-D-glucopyranosyl 2-O-hexadecanoyl-alpha-D-glucopyranoside

C28H51O15S- (659.2948516)


   
   
   

alpha-L-Rhap-(1->3)-beta-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->2)-alpha-L-Rhap

alpha-L-Rhap-(1->3)-beta-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->2)-alpha-L-Rhap

C26H45NO18 (659.263651)


   

6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

C26H45NO18 (659.263651)


   

6-{[alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl]oxy}hexanoic acid

6-{[alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl]oxy}hexanoic acid

C26H45NO18 (659.263651)


   
   

alpha-L-Rhap-(1->2)-[beta-D-GlcpNAc-(1->3)]-alpha-L-Rhap-(1->3)-alpha-L-Rhap

alpha-L-Rhap-(1->2)-[beta-D-GlcpNAc-(1->3)]-alpha-L-Rhap-(1->3)-alpha-L-Rhap

C26H45NO18 (659.263651)


   

6-[2-[(E,3E)-3-(4-tert-butyl-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),4,8-tetraen-6-ylidene)prop-1-enyl]-3,3-dimethyl-5-sulfoindol-1-ium-1-yl]hexanoic acid

6-[2-[(E,3E)-3-(4-tert-butyl-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),4,8-tetraen-6-ylidene)prop-1-enyl]-3,3-dimethyl-5-sulfoindol-1-ium-1-yl]hexanoic acid

C38H47N2O6S+ (659.3154662)